US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-01 07:25:26 Source：Cultural Compass news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Brit living in California shares how expensive it really is to live there
- Next：Using a walker boot for too long may mean you can't ever walk properly without it again
Related articles
- Ralph Lauren goes minimal for latest fashion show, with muted tones and a more intimate setting
- Ashley Judd, #MeToo founders react to ruling overturning Harvey Weinstein's conviction
- MLB presence in Mexico goes beyond just hosting another regular
- Judge upholds disqualification of challenger to judge in Trump’s Georgia election interference case
- DAILY MAIL COMMENT: A very good day for our united kingdom
- Female California teacher, 46, pleads no contest to raping 14 year
- Revealed: The 10 surprising foods experts say you should keep in the fridge
- US Silica agrees to go private in $1.85 billion acquisition by Apollo Global
- Walmart shutting down its 51 health care clinics, virtual care service
- Jayhawks sign Alabama's Rylan Griffen out of portal to address their 3
- Chinese astronauts return to earth after six months in space
- A ban in Kansas on gender
- A British tourist is in a hospital after a shark attack. Tobago closes several beaches
- Ashley Judd, #MeToo founders react to ruling overturning Harvey Weinstein's conviction
- 'Obsessed' ex
- Bairstow's unbeaten century leads Punjab to highest run chase in IPL history
- President Biden says he's 'happy to debate' Trump: Election 2024
- Heartbreaking moment loyal dog desperately chases its owners' car after it was dumped on road
- Lilly rides Mounjaro, Zepbound to better
- Sam Kerr's bid to get racially
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Cultural Compass news portal sitemap